Healthcare provider profile · identity verified

Brent S. Ingerick, DO

Family Practice · ELMIRA, NY · NPI 1669440707

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	425	130
Atorvastatin Calcium	Atorvastatin Calcium	415	131
Omeprazole	Omeprazole	305	92
Levothyroxine Sodium	Levothyroxine Sodium	282	82
Albuterol Sulfate Hfa	Albuterol Sulfate	206	75
Lisinopril	Lisinopril	202	64
Metoprolol Succinate	Metoprolol Succinate	197	59
Amlodipine Besylate	Amlodipine Besylate	167	51
Metformin Hcl Er	Metformin Hcl	162	53
Eliquis	Apixaban	127	31
Pantoprazole Sodium	Pantoprazole Sodium	127	45
Sertraline Hcl	Sertraline Hcl	120	35
Tamsulosin Hcl	Tamsulosin Hcl	119	38
Simvastatin	Simvastatin	118	37
Ramipril	Ramipril	113	37
Metformin Hcl	Metformin Hcl	112	33
Buspirone Hcl	Buspirone Hcl	103	25
Glipizide Er	Glipizide	102	28
Bupropion Xl	Bupropion Hcl	99	22
Gabapentin	Gabapentin	99	28
Irbesartan	Irbesartan	98	32
Zolpidem Tartrate	Zolpidem Tartrate	92	16
Montelukast Sodium	Montelukast Sodium	90	25
Losartan Potassium	Losartan Potassium	89	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	29
Allopurinol	Allopurinol	84	29
Hydrochlorothiazide	Hydrochlorothiazide	84	22
Escitalopram Oxalate	Escitalopram Oxalate	80	21
Ozempic	Semaglutide	80	13
Fluticasone Propionate	Fluticasone Propionate	79	25
Jardiance	Empagliflozin	78	19
Prednisone	Prednisone	65	51
Pregabalin	Pregabalin	65	15
Duloxetine Hcl	Duloxetine Hcl	64	20
Farxiga	Dapagliflozin Propanediol	64	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	62	18
Spironolactone	Spironolactone	60	14
Atenolol	Atenolol	57	18
Trazodone Hcl	Trazodone Hcl	57	24
Carvedilol	Carvedilol	56	14
Mounjaro	Tirzepatide	56	11
Metoprolol Tartrate	Metoprolol Tartrate	55	16
Nortriptyline Hcl	Nortriptyline Hcl	52	11
Rybelsus	Semaglutide	52	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	51	16
Potassium Chloride	Potassium Chloride	50	18
Clonidine Hcl	Clonidine Hcl	49	suppressed
Famotidine	Famotidine	47	11
Fluoxetine Hcl	Fluoxetine Hcl	47	14
Tramadol Hcl	Tramadol Hcl	46	17
Azithromycin	Azithromycin	44	30
Esomeprazole Magnesium	Esomeprazole Magnesium	44	12
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Synthroid	Levothyroxine Sodium	43	12
Alprazolam	Alprazolam	42	15
Trulicity	Dulaglutide	42	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	41	suppressed
Furosemide	Furosemide	40	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Solifenacin Succinate	Solifenacin Succinate	40	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	39	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	38	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	15
Meloxicam	Meloxicam	36	11
Celecoxib	Celecoxib	35	suppressed
Cephalexin	Cephalexin	34	16
Clonazepam	Clonazepam	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	11
Methocarbamol	Methocarbamol	30	12
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Terazosin Hcl	Terazosin Hcl	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Januvia	Sitagliptin Phosphate	28	suppressed
Torsemide	Torsemide	27	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Risedronate Sodium	Risedronate Sodium	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Baclofen	Baclofen	23	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Valacyclovir	Valacyclovir Hcl	22	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Ketoconazole	Ketoconazole	21	17
Lorazepam	Lorazepam	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	18
Xarelto	Rivaroxaban	19	suppressed
Finasteride	Finasteride	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Meclizine Hcl	Meclizine Hcl	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Diclofenac Potassium	Diclofenac Potassium	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Belsomra	Suvorexant	14	suppressed
Digoxin	Digoxin	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Amoxicillin	Amoxicillin	13	12
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Fluconazole	Fluconazole	13	11
Invokana	Canagliflozin	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Diazepam	Diazepam	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glipizide	Glipizide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error